Journal article
Identification and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes clones harboring tetracycline and macrolide resistance in Shanghai, China
Y Shen, J Cai, MR Davies, C Zhang, K Gao, D Qiao, H Jiang, W Yao, Y Li, M Zeng, M Chen
Frontiers in Microbiology | FRONTIERS MEDIA SA | Published : 2018
Abstract
Streptococcus pyogenes, also known as group A Streptococcus (GAS), is one of the top 10 infectious causes of death worldwide. Macrolide and tetracycline resistant GAS has emerged as a major health concern in China coinciding with an ongoing scarlet fever epidemic. Furthermore, increasing rates of fluoroquinolone (FQ) non-susceptibility within GAS from geographical regions outside of China has also been reported. Fluoroquinolones are the third most commonly prescribed antibiotic in China and is an therapeutic alternative for multi-drug resistant GAS. The purpose of this study was to investigate the epidemiological and molecular features of GAS fluoroquinolone (FQ) non-susceptibility in Shangh..
View full abstractRelated Projects (2)
Grants
Awarded by Natural Science Foundation of Shanghai
Funding Acknowledgements
This study was supported by grants from National Natural Science Foundation of China (81601801), Shanghai Rising-Star Program (17QA1403100), a Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai (2017YQ039), Natural Science Foundation of Shanghai (16ZR1433300), and Key project funded by Shanghai Municipal Commission of Health and Family Planning (201640002). MD is supported by the National Health and Medical Research Council of Australia (NHMRC) grants 1126805 and 1130455. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.